BIOCHEMICAL PHARMACOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2231919, encodeId=7c8222319197a, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：心血管 经验分享：3月18投稿 23就under review 4月14号的时候送审意见就回来了 状态是revise，给了一个月时间修改 5月16的时候修回去后状态一直是with editor 2天后也就是18号的时候变成了decision in process 19号接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822123, createdTime=Sun Oct 20 18:33:19 CST 2024, time=2024-10-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2207937, encodeId=9652220e93751, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：1.3 submitted，1.7 with editor，1.11 under review，2.8 时间变动状态不变 2.12,评审结束 2.22 DIP 2.24 reverse（1个月） 3.22 resubmitted 3.26 with editor 4.1 under review 4.3 评审结束 4.6 二返（半月），4.12 resubmitted, 4.19催稿，4.21接收，4.25 online。投稿共耗时4个月，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44f99168202, createdName=ms1000000537292872, createdTime=Sun Jun 02 17:13:38 CST 2024, time=2024-06-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2182826, encodeId=a36c2182826d1, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：胃癌;肿瘤免疫 经验分享：太慢了，我已经外审90天了，我的天，发邮件也不回，我要撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Sat Jan 20 13:28:54 CST 2024, time=2024-01-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2208736, encodeId=626e2208e36fc, content=5月20号投稿，23号with editor,到现在还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Fri Jun 07 00:51:29 CST 2024, time=2024-06-07, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2214390, encodeId=b997221439051, content=2024.1.30投稿 2024.5.30返修，时间一个月 2024.6.29返修回去现在还在等专家评审😭真的好久好久好久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3ea8115172, createdName=ms6000000678863567, createdTime=Thu Jul 11 10:12:32 CST 2024, time=2024-07-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2170993, encodeId=35c521e0993d1, content=送审后accept率高么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Sat Nov 25 22:46:29 CST 2023, time=2023-11-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2131034, encodeId=e8f521310341c, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：心血管疾病 经验分享：3月25号投稿，28号under review，4月14号送审意见就回来了，状态是revise,给了一个月时间修改，5月5号修回去，状态一直是with editor,7号变成了Decision in process,第二天直接接收。审稿人的意见只要合理的认真修改，应该没有问题，希望能帮到大家，祝好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b46161251, createdName=ms3000001240185836, createdTime=Mon May 08 22:30:06 CST 2023, time=2023-05-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2226256, encodeId=eba2222625694, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：5月20日投稿，7月中旬第一轮修改，8月中旬修回，到现在还在二审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Tue Sep 17 21:09:43 CST 2024, time=2024-09-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2222906, encodeId=c9da222290619, content=8月13第一轮修改完返稿，一直到今天还是with editor是咋回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Wed Aug 28 20:25:54 CST 2024, time=2024-08-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2225800, encodeId=e9ad222580030, content=通讯作者用的是163邮箱，会不会直接拒稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f43f8766568, createdName=ms9000000714416538, createdTime=Sat Sep 14 10:22:28 CST 2024, time=2024-09-14, status=1, ipAttribution=北京)]

2024-10-20 ms1000001788822123 来自上海

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：心血管
经验分享：3月18投稿
23就under review
4月14号的时候送审意见就回来了
状态是revise，给了一个月时间修改
5月16的时候修回去后状态一直是with editor
2天后也就是18号的时候变成了decision in process
19号接收。

1 0

[GetPortalCommentsPageByObjectIdResponse(id=2231919, encodeId=7c8222319197a, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：心血管 经验分享：3月18投稿 23就under review 4月14号的时候送审意见就回来了 状态是revise，给了一个月时间修改 5月16的时候修回去后状态一直是with editor 2天后也就是18号的时候变成了decision in process 19号接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822123, createdTime=Sun Oct 20 18:33:19 CST 2024, time=2024-10-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2207937, encodeId=9652220e93751, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：1.3 submitted，1.7 with editor，1.11 under review，2.8 时间变动状态不变 2.12,评审结束 2.22 DIP 2.24 reverse（1个月） 3.22 resubmitted 3.26 with editor 4.1 under review 4.3 评审结束 4.6 二返（半月），4.12 resubmitted, 4.19催稿，4.21接收，4.25 online。投稿共耗时4个月，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44f99168202, createdName=ms1000000537292872, createdTime=Sun Jun 02 17:13:38 CST 2024, time=2024-06-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2182826, encodeId=a36c2182826d1, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：胃癌;肿瘤免疫 经验分享：太慢了，我已经外审90天了，我的天，发邮件也不回，我要撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Sat Jan 20 13:28:54 CST 2024, time=2024-01-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2208736, encodeId=626e2208e36fc, content=5月20号投稿，23号with editor,到现在还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Fri Jun 07 00:51:29 CST 2024, time=2024-06-07, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2214390, encodeId=b997221439051, content=2024.1.30投稿 2024.5.30返修，时间一个月 2024.6.29返修回去现在还在等专家评审😭真的好久好久好久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3ea8115172, createdName=ms6000000678863567, createdTime=Thu Jul 11 10:12:32 CST 2024, time=2024-07-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2170993, encodeId=35c521e0993d1, content=送审后accept率高么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Sat Nov 25 22:46:29 CST 2023, time=2023-11-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2131034, encodeId=e8f521310341c, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：心血管疾病 经验分享：3月25号投稿，28号under review，4月14号送审意见就回来了，状态是revise,给了一个月时间修改，5月5号修回去，状态一直是with editor,7号变成了Decision in process,第二天直接接收。审稿人的意见只要合理的认真修改，应该没有问题，希望能帮到大家，祝好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b46161251, createdName=ms3000001240185836, createdTime=Mon May 08 22:30:06 CST 2023, time=2023-05-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2226256, encodeId=eba2222625694, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：5月20日投稿，7月中旬第一轮修改，8月中旬修回，到现在还在二审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Tue Sep 17 21:09:43 CST 2024, time=2024-09-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2222906, encodeId=c9da222290619, content=8月13第一轮修改完返稿，一直到今天还是with editor是咋回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Wed Aug 28 20:25:54 CST 2024, time=2024-08-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2225800, encodeId=e9ad222580030, content=通讯作者用的是163邮箱，会不会直接拒稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f43f8766568, createdName=ms9000000714416538, createdTime=Sat Sep 14 10:22:28 CST 2024, time=2024-09-14, status=1, ipAttribution=北京)]

2024-06-02 ms1000000537292872 来自河北省

审稿速度:1.0 | 投稿命中率:50.0
经验分享：1.3 submitted，1.7 with editor，1.11 under review，2.8 时间变动状态不变 2.12,评审结束 2.22 DIP 2.24 reverse（1个月） 3.22 resubmitted 3.26 with editor 4.1 under review 4.3 评审结束 4.6 二返（半月），4.12 resubmitted, 4.19催稿，4.21接收，4.25 online。投稿共耗时4个月，

77 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2231919, encodeId=7c8222319197a, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：心血管 经验分享：3月18投稿 23就under review 4月14号的时候送审意见就回来了 状态是revise，给了一个月时间修改 5月16的时候修回去后状态一直是with editor 2天后也就是18号的时候变成了decision in process 19号接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822123, createdTime=Sun Oct 20 18:33:19 CST 2024, time=2024-10-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2207937, encodeId=9652220e93751, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：1.3 submitted，1.7 with editor，1.11 under review，2.8 时间变动状态不变 2.12,评审结束 2.22 DIP 2.24 reverse（1个月） 3.22 resubmitted 3.26 with editor 4.1 under review 4.3 评审结束 4.6 二返（半月），4.12 resubmitted, 4.19催稿，4.21接收，4.25 online。投稿共耗时4个月，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44f99168202, createdName=ms1000000537292872, createdTime=Sun Jun 02 17:13:38 CST 2024, time=2024-06-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2182826, encodeId=a36c2182826d1, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：胃癌;肿瘤免疫 经验分享：太慢了，我已经外审90天了，我的天，发邮件也不回，我要撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Sat Jan 20 13:28:54 CST 2024, time=2024-01-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2208736, encodeId=626e2208e36fc, content=5月20号投稿，23号with editor,到现在还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Fri Jun 07 00:51:29 CST 2024, time=2024-06-07, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2214390, encodeId=b997221439051, content=2024.1.30投稿 2024.5.30返修，时间一个月 2024.6.29返修回去现在还在等专家评审😭真的好久好久好久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3ea8115172, createdName=ms6000000678863567, createdTime=Thu Jul 11 10:12:32 CST 2024, time=2024-07-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2170993, encodeId=35c521e0993d1, content=送审后accept率高么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Sat Nov 25 22:46:29 CST 2023, time=2023-11-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2131034, encodeId=e8f521310341c, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：心血管疾病 经验分享：3月25号投稿，28号under review，4月14号送审意见就回来了，状态是revise,给了一个月时间修改，5月5号修回去，状态一直是with editor,7号变成了Decision in process,第二天直接接收。审稿人的意见只要合理的认真修改，应该没有问题，希望能帮到大家，祝好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b46161251, createdName=ms3000001240185836, createdTime=Mon May 08 22:30:06 CST 2023, time=2023-05-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2226256, encodeId=eba2222625694, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：5月20日投稿，7月中旬第一轮修改，8月中旬修回，到现在还在二审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Tue Sep 17 21:09:43 CST 2024, time=2024-09-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2222906, encodeId=c9da222290619, content=8月13第一轮修改完返稿，一直到今天还是with editor是咋回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Wed Aug 28 20:25:54 CST 2024, time=2024-08-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2225800, encodeId=e9ad222580030, content=通讯作者用的是163邮箱，会不会直接拒稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f43f8766568, createdName=ms9000000714416538, createdTime=Sat Sep 14 10:22:28 CST 2024, time=2024-09-14, status=1, ipAttribution=北京)]

2024-01-20 ms9000001327347856 来自上海

审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：胃癌;肿瘤免疫
经验分享：太慢了，我已经外审90天了，我的天，发邮件也不回，我要撤稿了

67 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2231919, encodeId=7c8222319197a, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：心血管 经验分享：3月18投稿 23就under review 4月14号的时候送审意见就回来了 状态是revise，给了一个月时间修改 5月16的时候修回去后状态一直是with editor 2天后也就是18号的时候变成了decision in process 19号接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822123, createdTime=Sun Oct 20 18:33:19 CST 2024, time=2024-10-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2207937, encodeId=9652220e93751, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：1.3 submitted，1.7 with editor，1.11 under review，2.8 时间变动状态不变 2.12,评审结束 2.22 DIP 2.24 reverse（1个月） 3.22 resubmitted 3.26 with editor 4.1 under review 4.3 评审结束 4.6 二返（半月），4.12 resubmitted, 4.19催稿，4.21接收，4.25 online。投稿共耗时4个月，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44f99168202, createdName=ms1000000537292872, createdTime=Sun Jun 02 17:13:38 CST 2024, time=2024-06-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2182826, encodeId=a36c2182826d1, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：胃癌;肿瘤免疫 经验分享：太慢了，我已经外审90天了，我的天，发邮件也不回，我要撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Sat Jan 20 13:28:54 CST 2024, time=2024-01-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2208736, encodeId=626e2208e36fc, content=5月20号投稿，23号with editor,到现在还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Fri Jun 07 00:51:29 CST 2024, time=2024-06-07, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2214390, encodeId=b997221439051, content=2024.1.30投稿 2024.5.30返修，时间一个月 2024.6.29返修回去现在还在等专家评审😭真的好久好久好久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3ea8115172, createdName=ms6000000678863567, createdTime=Thu Jul 11 10:12:32 CST 2024, time=2024-07-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2170993, encodeId=35c521e0993d1, content=送审后accept率高么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Sat Nov 25 22:46:29 CST 2023, time=2023-11-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2131034, encodeId=e8f521310341c, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：心血管疾病 经验分享：3月25号投稿，28号under review，4月14号送审意见就回来了，状态是revise,给了一个月时间修改，5月5号修回去，状态一直是with editor,7号变成了Decision in process,第二天直接接收。审稿人的意见只要合理的认真修改，应该没有问题，希望能帮到大家，祝好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b46161251, createdName=ms3000001240185836, createdTime=Mon May 08 22:30:06 CST 2023, time=2023-05-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2226256, encodeId=eba2222625694, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：5月20日投稿，7月中旬第一轮修改，8月中旬修回，到现在还在二审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Tue Sep 17 21:09:43 CST 2024, time=2024-09-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2222906, encodeId=c9da222290619, content=8月13第一轮修改完返稿，一直到今天还是with editor是咋回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Wed Aug 28 20:25:54 CST 2024, time=2024-08-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2225800, encodeId=e9ad222580030, content=通讯作者用的是163邮箱，会不会直接拒稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f43f8766568, createdName=ms9000000714416538, createdTime=Sat Sep 14 10:22:28 CST 2024, time=2024-09-14, status=1, ipAttribution=北京)]

2024-06-07 147a5c7fm07(暂无昵称) 来自吉林省

5月20号投稿，23号with editor,到现在还没动静

68 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2231919, encodeId=7c8222319197a, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：心血管 经验分享：3月18投稿 23就under review 4月14号的时候送审意见就回来了 状态是revise，给了一个月时间修改 5月16的时候修回去后状态一直是with editor 2天后也就是18号的时候变成了decision in process 19号接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822123, createdTime=Sun Oct 20 18:33:19 CST 2024, time=2024-10-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2207937, encodeId=9652220e93751, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：1.3 submitted，1.7 with editor，1.11 under review，2.8 时间变动状态不变 2.12,评审结束 2.22 DIP 2.24 reverse（1个月） 3.22 resubmitted 3.26 with editor 4.1 under review 4.3 评审结束 4.6 二返（半月），4.12 resubmitted, 4.19催稿，4.21接收，4.25 online。投稿共耗时4个月，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44f99168202, createdName=ms1000000537292872, createdTime=Sun Jun 02 17:13:38 CST 2024, time=2024-06-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2182826, encodeId=a36c2182826d1, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：胃癌;肿瘤免疫 经验分享：太慢了，我已经外审90天了，我的天，发邮件也不回，我要撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Sat Jan 20 13:28:54 CST 2024, time=2024-01-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2208736, encodeId=626e2208e36fc, content=5月20号投稿，23号with editor,到现在还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Fri Jun 07 00:51:29 CST 2024, time=2024-06-07, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2214390, encodeId=b997221439051, content=2024.1.30投稿 2024.5.30返修，时间一个月 2024.6.29返修回去现在还在等专家评审😭真的好久好久好久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3ea8115172, createdName=ms6000000678863567, createdTime=Thu Jul 11 10:12:32 CST 2024, time=2024-07-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2170993, encodeId=35c521e0993d1, content=送审后accept率高么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Sat Nov 25 22:46:29 CST 2023, time=2023-11-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2131034, encodeId=e8f521310341c, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：心血管疾病 经验分享：3月25号投稿，28号under review，4月14号送审意见就回来了，状态是revise,给了一个月时间修改，5月5号修回去，状态一直是with editor,7号变成了Decision in process,第二天直接接收。审稿人的意见只要合理的认真修改，应该没有问题，希望能帮到大家，祝好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b46161251, createdName=ms3000001240185836, createdTime=Mon May 08 22:30:06 CST 2023, time=2023-05-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2226256, encodeId=eba2222625694, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：5月20日投稿，7月中旬第一轮修改，8月中旬修回，到现在还在二审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Tue Sep 17 21:09:43 CST 2024, time=2024-09-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2222906, encodeId=c9da222290619, content=8月13第一轮修改完返稿，一直到今天还是with editor是咋回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Wed Aug 28 20:25:54 CST 2024, time=2024-08-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2225800, encodeId=e9ad222580030, content=通讯作者用的是163邮箱，会不会直接拒稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f43f8766568, createdName=ms9000000714416538, createdTime=Sat Sep 14 10:22:28 CST 2024, time=2024-09-14, status=1, ipAttribution=北京)]

2024-07-11 ms6000000678863567 来自湖北省

2024.1.30投稿 2024.5.30返修，时间一个月 2024.6.29返修回去现在还在等专家评审😭真的好久好久好久啊

66 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2231919, encodeId=7c8222319197a, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：心血管 经验分享：3月18投稿 23就under review 4月14号的时候送审意见就回来了 状态是revise，给了一个月时间修改 5月16的时候修回去后状态一直是with editor 2天后也就是18号的时候变成了decision in process 19号接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822123, createdTime=Sun Oct 20 18:33:19 CST 2024, time=2024-10-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2207937, encodeId=9652220e93751, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：1.3 submitted，1.7 with editor，1.11 under review，2.8 时间变动状态不变 2.12,评审结束 2.22 DIP 2.24 reverse（1个月） 3.22 resubmitted 3.26 with editor 4.1 under review 4.3 评审结束 4.6 二返（半月），4.12 resubmitted, 4.19催稿，4.21接收，4.25 online。投稿共耗时4个月，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44f99168202, createdName=ms1000000537292872, createdTime=Sun Jun 02 17:13:38 CST 2024, time=2024-06-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2182826, encodeId=a36c2182826d1, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：胃癌;肿瘤免疫 经验分享：太慢了，我已经外审90天了，我的天，发邮件也不回，我要撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Sat Jan 20 13:28:54 CST 2024, time=2024-01-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2208736, encodeId=626e2208e36fc, content=5月20号投稿，23号with editor,到现在还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Fri Jun 07 00:51:29 CST 2024, time=2024-06-07, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2214390, encodeId=b997221439051, content=2024.1.30投稿 2024.5.30返修，时间一个月 2024.6.29返修回去现在还在等专家评审😭真的好久好久好久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3ea8115172, createdName=ms6000000678863567, createdTime=Thu Jul 11 10:12:32 CST 2024, time=2024-07-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2170993, encodeId=35c521e0993d1, content=送审后accept率高么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Sat Nov 25 22:46:29 CST 2023, time=2023-11-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2131034, encodeId=e8f521310341c, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：心血管疾病 经验分享：3月25号投稿，28号under review，4月14号送审意见就回来了，状态是revise,给了一个月时间修改，5月5号修回去，状态一直是with editor,7号变成了Decision in process,第二天直接接收。审稿人的意见只要合理的认真修改，应该没有问题，希望能帮到大家，祝好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b46161251, createdName=ms3000001240185836, createdTime=Mon May 08 22:30:06 CST 2023, time=2023-05-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2226256, encodeId=eba2222625694, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：5月20日投稿，7月中旬第一轮修改，8月中旬修回，到现在还在二审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Tue Sep 17 21:09:43 CST 2024, time=2024-09-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2222906, encodeId=c9da222290619, content=8月13第一轮修改完返稿，一直到今天还是with editor是咋回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Wed Aug 28 20:25:54 CST 2024, time=2024-08-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2225800, encodeId=e9ad222580030, content=通讯作者用的是163邮箱，会不会直接拒稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f43f8766568, createdName=ms9000000714416538, createdTime=Sat Sep 14 10:22:28 CST 2024, time=2024-09-14, status=1, ipAttribution=北京)]

2023-11-25 ms6000002140643083 来自安徽省

送审后accept率高么

45 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2231919, encodeId=7c8222319197a, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：心血管 经验分享：3月18投稿 23就under review 4月14号的时候送审意见就回来了 状态是revise，给了一个月时间修改 5月16的时候修回去后状态一直是with editor 2天后也就是18号的时候变成了decision in process 19号接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822123, createdTime=Sun Oct 20 18:33:19 CST 2024, time=2024-10-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2207937, encodeId=9652220e93751, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：1.3 submitted，1.7 with editor，1.11 under review，2.8 时间变动状态不变 2.12,评审结束 2.22 DIP 2.24 reverse（1个月） 3.22 resubmitted 3.26 with editor 4.1 under review 4.3 评审结束 4.6 二返（半月），4.12 resubmitted, 4.19催稿，4.21接收，4.25 online。投稿共耗时4个月，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44f99168202, createdName=ms1000000537292872, createdTime=Sun Jun 02 17:13:38 CST 2024, time=2024-06-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2182826, encodeId=a36c2182826d1, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：胃癌;肿瘤免疫 经验分享：太慢了，我已经外审90天了，我的天，发邮件也不回，我要撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Sat Jan 20 13:28:54 CST 2024, time=2024-01-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2208736, encodeId=626e2208e36fc, content=5月20号投稿，23号with editor,到现在还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Fri Jun 07 00:51:29 CST 2024, time=2024-06-07, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2214390, encodeId=b997221439051, content=2024.1.30投稿 2024.5.30返修，时间一个月 2024.6.29返修回去现在还在等专家评审😭真的好久好久好久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3ea8115172, createdName=ms6000000678863567, createdTime=Thu Jul 11 10:12:32 CST 2024, time=2024-07-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2170993, encodeId=35c521e0993d1, content=送审后accept率高么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Sat Nov 25 22:46:29 CST 2023, time=2023-11-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2131034, encodeId=e8f521310341c, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：心血管疾病 经验分享：3月25号投稿，28号under review，4月14号送审意见就回来了，状态是revise,给了一个月时间修改，5月5号修回去，状态一直是with editor,7号变成了Decision in process,第二天直接接收。审稿人的意见只要合理的认真修改，应该没有问题，希望能帮到大家，祝好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b46161251, createdName=ms3000001240185836, createdTime=Mon May 08 22:30:06 CST 2023, time=2023-05-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2226256, encodeId=eba2222625694, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：5月20日投稿，7月中旬第一轮修改，8月中旬修回，到现在还在二审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Tue Sep 17 21:09:43 CST 2024, time=2024-09-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2222906, encodeId=c9da222290619, content=8月13第一轮修改完返稿，一直到今天还是with editor是咋回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Wed Aug 28 20:25:54 CST 2024, time=2024-08-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2225800, encodeId=e9ad222580030, content=通讯作者用的是163邮箱，会不会直接拒稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f43f8766568, createdName=ms9000000714416538, createdTime=Sat Sep 14 10:22:28 CST 2024, time=2024-09-14, status=1, ipAttribution=北京)]

2023-05-08 ms3000001240185836 来自四川省

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：心血管疾病
经验分享：3月25号投稿，28号under review，4月14号送审意见就回来了，状态是revise,给了一个月时间修改，5月5号修回去，状态一直是with editor,7号变成了Decision in process,第二天直接接收。审稿人的意见只要合理的认真修改，应该没有问题，希望能帮到大家，祝好运。

127 30

展开30条回复

[GetPortalCommentsPageByObjectIdResponse(id=2231919, encodeId=7c8222319197a, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：心血管 经验分享：3月18投稿 23就under review 4月14号的时候送审意见就回来了 状态是revise，给了一个月时间修改 5月16的时候修回去后状态一直是with editor 2天后也就是18号的时候变成了decision in process 19号接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822123, createdTime=Sun Oct 20 18:33:19 CST 2024, time=2024-10-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2207937, encodeId=9652220e93751, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：1.3 submitted，1.7 with editor，1.11 under review，2.8 时间变动状态不变 2.12,评审结束 2.22 DIP 2.24 reverse（1个月） 3.22 resubmitted 3.26 with editor 4.1 under review 4.3 评审结束 4.6 二返（半月），4.12 resubmitted, 4.19催稿，4.21接收，4.25 online。投稿共耗时4个月，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44f99168202, createdName=ms1000000537292872, createdTime=Sun Jun 02 17:13:38 CST 2024, time=2024-06-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2182826, encodeId=a36c2182826d1, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：胃癌;肿瘤免疫 经验分享：太慢了，我已经外审90天了，我的天，发邮件也不回，我要撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Sat Jan 20 13:28:54 CST 2024, time=2024-01-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2208736, encodeId=626e2208e36fc, content=5月20号投稿，23号with editor,到现在还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Fri Jun 07 00:51:29 CST 2024, time=2024-06-07, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2214390, encodeId=b997221439051, content=2024.1.30投稿 2024.5.30返修，时间一个月 2024.6.29返修回去现在还在等专家评审😭真的好久好久好久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3ea8115172, createdName=ms6000000678863567, createdTime=Thu Jul 11 10:12:32 CST 2024, time=2024-07-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2170993, encodeId=35c521e0993d1, content=送审后accept率高么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Sat Nov 25 22:46:29 CST 2023, time=2023-11-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2131034, encodeId=e8f521310341c, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：心血管疾病 经验分享：3月25号投稿，28号under review，4月14号送审意见就回来了，状态是revise,给了一个月时间修改，5月5号修回去，状态一直是with editor,7号变成了Decision in process,第二天直接接收。审稿人的意见只要合理的认真修改，应该没有问题，希望能帮到大家，祝好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b46161251, createdName=ms3000001240185836, createdTime=Mon May 08 22:30:06 CST 2023, time=2023-05-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2226256, encodeId=eba2222625694, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：5月20日投稿，7月中旬第一轮修改，8月中旬修回，到现在还在二审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Tue Sep 17 21:09:43 CST 2024, time=2024-09-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2222906, encodeId=c9da222290619, content=8月13第一轮修改完返稿，一直到今天还是with editor是咋回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Wed Aug 28 20:25:54 CST 2024, time=2024-08-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2225800, encodeId=e9ad222580030, content=通讯作者用的是163邮箱，会不会直接拒稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f43f8766568, createdName=ms9000000714416538, createdTime=Sat Sep 14 10:22:28 CST 2024, time=2024-09-14, status=1, ipAttribution=北京)]

2024-09-17 147a5c7fm07(暂无昵称) 来自吉林省

审稿速度:6.0 | 投稿命中率:25.0
经验分享：5月20日投稿，7月中旬第一轮修改，8月中旬修回，到现在还在二审

9 0

[GetPortalCommentsPageByObjectIdResponse(id=2231919, encodeId=7c8222319197a, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：心血管 经验分享：3月18投稿 23就under review 4月14号的时候送审意见就回来了 状态是revise，给了一个月时间修改 5月16的时候修回去后状态一直是with editor 2天后也就是18号的时候变成了decision in process 19号接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822123, createdTime=Sun Oct 20 18:33:19 CST 2024, time=2024-10-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2207937, encodeId=9652220e93751, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：1.3 submitted，1.7 with editor，1.11 under review，2.8 时间变动状态不变 2.12,评审结束 2.22 DIP 2.24 reverse（1个月） 3.22 resubmitted 3.26 with editor 4.1 under review 4.3 评审结束 4.6 二返（半月），4.12 resubmitted, 4.19催稿，4.21接收，4.25 online。投稿共耗时4个月，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44f99168202, createdName=ms1000000537292872, createdTime=Sun Jun 02 17:13:38 CST 2024, time=2024-06-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2182826, encodeId=a36c2182826d1, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：胃癌;肿瘤免疫 经验分享：太慢了，我已经外审90天了，我的天，发邮件也不回，我要撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Sat Jan 20 13:28:54 CST 2024, time=2024-01-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2208736, encodeId=626e2208e36fc, content=5月20号投稿，23号with editor,到现在还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Fri Jun 07 00:51:29 CST 2024, time=2024-06-07, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2214390, encodeId=b997221439051, content=2024.1.30投稿 2024.5.30返修，时间一个月 2024.6.29返修回去现在还在等专家评审😭真的好久好久好久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3ea8115172, createdName=ms6000000678863567, createdTime=Thu Jul 11 10:12:32 CST 2024, time=2024-07-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2170993, encodeId=35c521e0993d1, content=送审后accept率高么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Sat Nov 25 22:46:29 CST 2023, time=2023-11-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2131034, encodeId=e8f521310341c, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：心血管疾病 经验分享：3月25号投稿，28号under review，4月14号送审意见就回来了，状态是revise,给了一个月时间修改，5月5号修回去，状态一直是with editor,7号变成了Decision in process,第二天直接接收。审稿人的意见只要合理的认真修改，应该没有问题，希望能帮到大家，祝好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b46161251, createdName=ms3000001240185836, createdTime=Mon May 08 22:30:06 CST 2023, time=2023-05-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2226256, encodeId=eba2222625694, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：5月20日投稿，7月中旬第一轮修改，8月中旬修回，到现在还在二审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Tue Sep 17 21:09:43 CST 2024, time=2024-09-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2222906, encodeId=c9da222290619, content=8月13第一轮修改完返稿，一直到今天还是with editor是咋回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Wed Aug 28 20:25:54 CST 2024, time=2024-08-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2225800, encodeId=e9ad222580030, content=通讯作者用的是163邮箱，会不会直接拒稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f43f8766568, createdName=ms9000000714416538, createdTime=Sat Sep 14 10:22:28 CST 2024, time=2024-09-14, status=1, ipAttribution=北京)]

2024-08-28 147a5c7fm07(暂无昵称) 来自吉林省

8月13第一轮修改完返稿，一直到今天还是with editor是咋回事啊

28 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2231919, encodeId=7c8222319197a, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：心血管 经验分享：3月18投稿 23就under review 4月14号的时候送审意见就回来了 状态是revise，给了一个月时间修改 5月16的时候修回去后状态一直是with editor 2天后也就是18号的时候变成了decision in process 19号接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms1000001788822123, createdTime=Sun Oct 20 18:33:19 CST 2024, time=2024-10-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2207937, encodeId=9652220e93751, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：1.3 submitted，1.7 with editor，1.11 under review，2.8 时间变动状态不变 2.12,评审结束 2.22 DIP 2.24 reverse（1个月） 3.22 resubmitted 3.26 with editor 4.1 under review 4.3 评审结束 4.6 二返（半月），4.12 resubmitted, 4.19催稿，4.21接收，4.25 online。投稿共耗时4个月，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44f99168202, createdName=ms1000000537292872, createdTime=Sun Jun 02 17:13:38 CST 2024, time=2024-06-02, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2182826, encodeId=a36c2182826d1, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：胃癌;肿瘤免疫 经验分享：太慢了，我已经外审90天了，我的天，发邮件也不回，我要撤稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=11f06507596, createdName=ms9000001327347856, createdTime=Sat Jan 20 13:28:54 CST 2024, time=2024-01-20, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2208736, encodeId=626e2208e36fc, content=5月20号投稿，23号with editor,到现在还没动静, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Fri Jun 07 00:51:29 CST 2024, time=2024-06-07, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2214390, encodeId=b997221439051, content=2024.1.30投稿 2024.5.30返修，时间一个月 2024.6.29返修回去现在还在等专家评审😭真的好久好久好久啊 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3ea8115172, createdName=ms6000000678863567, createdTime=Thu Jul 11 10:12:32 CST 2024, time=2024-07-11, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2170993, encodeId=35c521e0993d1, content=送审后accept率高么, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=45, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f84d5486747, createdName=ms6000002140643083, createdTime=Sat Nov 25 22:46:29 CST 2023, time=2023-11-25, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2131034, encodeId=e8f521310341c, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：心血管疾病 经验分享：3月25号投稿，28号under review，4月14号送审意见就回来了，状态是revise,给了一个月时间修改，5月5号修回去，状态一直是with editor,7号变成了Decision in process,第二天直接接收。审稿人的意见只要合理的认真修改，应该没有问题，希望能帮到大家，祝好运。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=30, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e9b46161251, createdName=ms3000001240185836, createdTime=Mon May 08 22:30:06 CST 2023, time=2023-05-08, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2226256, encodeId=eba2222625694, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：5月20日投稿，7月中旬第一轮修改，8月中旬修回，到现在还在二审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Tue Sep 17 21:09:43 CST 2024, time=2024-09-17, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2222906, encodeId=c9da222290619, content=8月13第一轮修改完返稿，一直到今天还是with editor是咋回事啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b04d5233363, createdName=147a5c7fm07(暂无昵称), createdTime=Wed Aug 28 20:25:54 CST 2024, time=2024-08-28, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=2225800, encodeId=e9ad222580030, content=通讯作者用的是163邮箱，会不会直接拒稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f43f8766568, createdName=ms9000000714416538, createdTime=Sat Sep 14 10:22:28 CST 2024, time=2024-09-14, status=1, ipAttribution=北京)]

2024-09-14 ms9000000714416538 来自北京

通讯作者用的是163邮箱，会不会直接拒稿啊

13 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务